Biologics And Biosimilars Market Size And Share

  • Report Code : TIPRE00008228
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025 年至 2031 年生物制剂和生物仿制药市场规模、份额及预测

Buy Now

Biologics and Biosimilars Market Report Biologics and Biosimilars Market Scope and Analysis Biologics and Biosimilars Market Size and Share

Biologics and Biosimilars Market Report Analysis

Biologics and Biosimilars Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Pfizer Inc.
  • Intas Pharmaceuticals Ltd.
  • Biocon
  • Dr. Reddys Laboratories Ltd.
  • Sandoz International GmbH (Novartis division)
  • CELLTRION INC.
  • Amgen Inc.
  • STADA Arzneimittel AG
  • Apotex Inc.

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 产品
  • 重组糖基化蛋白
  • 重组非糖基化蛋白
By 适应症
  • 慢性病
  • 肿瘤
  • 自身免疫性疾病
  • 传染病
  • 血液疾病
  • 生长激素缺乏症
  • 其他
By 地理
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲